Inogen INGN
NASDAQ INGN
$5.61 +0.01 (+0.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

Inogen (INGN) Net Equity Issued and Repurchased (2025)

Inogen (INGN) posted quarterly Net Equity Issued and Repurchased of $27.2 million for Q1 2025.

Inogen (INGN) Net Equity Issued and Repurchased (2025) Analysis & Trends

Inogen (INGN) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $27.2 million the latest figure, recorded in Q1 2025.

  • In Q1 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $27.2 million; the TTM figure through Dec 2025 stood at $27.2 million (changed N/A YoY), while the FY2025 annual figure was $27.2 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased steadied at $27.2 million in Q1 2025 per INGN's latest filing.
  • Across five years, Net Equity Issued and Repurchased topped out at $27.2 million in Q1 2025 and bottomed at $27.2 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Inogen 152.26 Mn 46.72 Mn 43.27 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 27.21 Mn
Mar 31, 2025 27.21 Mn